All of the company's key metrics are heading in the right direction.
Shockwave Medical's stock market debut got buried amid the recent surge of better-known offerings, but we’re digging this gem back out.
Shares jump after the company posts a strong start to the fiscal year and boost guidance.
Shares nose-dive after the company announces a surprise acquisition. Here's what investors need to know.
The visual search engine has been public for about a month. Is this a growth story that should excite investors?
Even geopolitical uncertainty can't slow the specialty software maker down.
Pinterest, DocuSign, and Upwork have had three very different entries to the market.
Which retail pharma giant is the better choice for investors today?
Shares slid after the company reported mixed first-quarter results and issued tepid guidance. Here's what investors need to know.
The cloud-based software company is hiring like crazy in an effort to drive its next phase of growth.
Unexpected costs are hitting the government software provider's bottom line hard.
Shares rise after the company receives some praise from a pair of Wall Street analysts.
Traders knock down the stock in response to an analyst downgrade.
The medical device maker's first earnings report as a public company featured explosive revenue growth and upbeat full-year guidance.
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
Traders bid up the stock in response to another strong earnings report.
The cybersecurity company reported good first-quarter results but stated that its business momentum is slowing down.
The company is winning its fair share of new business, but some big projects are taking a long time to come to fruition.
First-quarter results looked good, but the company's guidance left investors wanting more.
Shares fall hard after the company reported mixed first-quarter results and issued weak guidance.